The announcement is made by April Giles, President & CEO of the Colorado BioScience Association (CBSA) who says, “Leading biotech, medical device, diagnostic and pharmaceutical investors from across the country will be coming to Denver to connect and invest in the regions emerging life science companies. Each company will make a 10-minute presentation to an audience of their peers, investors and partners, followed by a 5-minute period of questions—this type of high-pressure pitching is typical in vying for highly coveted VC funding.”
“The RMLIPC really showcases the best companies from the region and provides investors an opportunity to evaluate these fresh investment opportunities and meet one-on-one with their founders and executive team,” said Giles. “It’s important to note, the Rocky Mountain region is a key player in the life science industry. There has been over $1 billion in investment in the region over the past five years.”
The following investors and strategic partners will be attending RMLIPC 2013:
Amgen Ventures, Thousand Oaks, CA - http://www.amgen.com/partners/amgen_ventures
Aphelion Capital, Mill Valley, CA - http://www.aphelioncapital.net
Bay City Capital, San Francisco, CA - http://www.baycitycapital.com
Boulder Ventures, Boulder, CO - http://www.boulderventures.com
Charter Life Sciences,
Santa Clara, CA - http://www.charterls.com
Covidien, Mansfield, MA - http://www.covidien.com
GE Healthcare Financial Services, Chicago,
IL - http://www.gehealthcarefinance.com
Goodworks Ventures, MT - http://www.goodworksventures.com
High Country Venture, Boulder, CO - http://highcountryventure.com
Johnson & Johnson Development
Corporation, New Brunswick, NJ - http://www.jjdevcorp.com
KMG Capital Partners, Denver CO
Level 5 Partners, Fort Collins, CO - http://l5partners.com
Lightstone Ventures, Boulder, CO - http://lightstonevc.com
Mercury Fund, Houston, TX - http://www.mercuryfund.com
Mile High Fund, Denver, CO - http://www.comilehighfund.com
Morgenthaler Ventures, Menlo Park, CA - http://www.morgenthaler.com
New Enterprise Associates, Menlo Park,
CA - http://www.nea.com
Novartis Venture Funds, Cambridge, MA
- http://www.venturefund.novartis.com
Red Script Ventures, New Brunswick, NJ
- http://www.jjdevcorp.com
Remeditex, Dallas, TX - http://remeditex.com
Salt Lake Life Science Angels, Salt
Lake City, UT - http://www.sllsa.com
Sanderling Ventures, San
Mateo, CA - http://www.sanderling.com
Signal Peak Ventures, Salt Lake City,
UT - http://signalpeakvc.com
Silicon Valley Bank,
Broomfield, CO - http://www.svb.com
Split Rock Partners, Menlo
Park, CA - http://www.splitrock.com
SR One, Corporate VC Arm
of GlaxoSmithKline, San Francisco, CA - http://www.srone.com
Volcano Capital, New York, NY - http://www.volcanocap.com
Wayne Brown Institute, Salt Lake City,
UT - http://www.waynebrowninstitute.org
Wexford Capital LP, Greenwich, CT - http://www.wexford.com
About the Rocky Mountain Life Science Investor & Partnering Conference
The 2013 Rocky Mountain Life Science Investor & Partnering Conference – spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a reception at the Colorado Governor’s Mansion September 18th and follow with a full day of company pitch presentations September 19th. The keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies-Patrick Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The keynote lunch titled “New Approaches to Healthcare Innovation” will be a presentation from Jeff Calcagno, M.D., Venture Investments with Johnson & Johnson Development Corporation. For more information and registration details, visit http://www.RockyMtnBioInvest.com.
On Twitter, please use the hashtag #RockyMtnBioInvest for your tweets.
No comments:
Post a Comment